Zobrazeno 1 - 10
of 1 005
pro vyhledávání: '"Fearns, R."'
Autor:
Zhao C; Division of Newborn Medicine, Department of Pediatrics and., Bai Y; Division of Newborn Medicine, Department of Pediatrics and., Wang W; Division of Newborn Medicine, Department of Pediatrics and., Amonkar GM; Division of Newborn Medicine, Department of Pediatrics and., Mou H; The Mucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Boston, Massachusetts, USA., Olejnik J; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA., Hume AJ; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA., Mühlberger E; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA., Lukacs NW; Mary H. Weiser Food Allergy Center, University of Michigan, Ann Arbor, Michigan, USA., Fearns R; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA., Lerou PH; Division of Newborn Medicine, Department of Pediatrics and., Ai X; Division of Newborn Medicine, Department of Pediatrics and.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2024 Nov 01; Vol. 134 (21). Date of Electronic Publication: 2024 Nov 01.
Autor:
Yu X; Johnson & Johnson Innovative Medicine, Spring House, Pennsylvania, PA, 19477, USA. xyu6@its.jnj.com., Abeywickrema P; Johnson & Johnson Innovative Medicine, Spring House, Pennsylvania, PA, 19477, USA., Bonneux B; Janssen Infectious Diseases and Vaccines, 2340, Beerse, Belgium.; University of Antwerp, Antwerp, Belgium., Behera I; Johnson & Johnson Innovative Medicine, Brisbane, CA, 94005, USA., Anson B; Johnson & Johnson Innovative Medicine, Brisbane, CA, 94005, USA., Jacoby E; Johnson & Johnson Innovative Medicine, Beerse, Belgium., Fung A; Johnson & Johnson Innovative Medicine, Brisbane, CA, 94005, USA., Adhikary S; Johnson & Johnson Innovative Medicine, Spring House, Pennsylvania, PA, 19477, USA., Bhaumik A; Johnson & Johnson Innovative Medicine, Spring House, Pennsylvania, PA, 19477, USA., Carbajo RJ; Johnson & Johnson Innovative Medicine, Janssen-Cilag, Discovery Chemistry S.A. Río Jarama, 75A, 45007, Toledo, Spain., De Bruyn S; Janssen Infectious Diseases and Vaccines, 2340, Beerse, Belgium., Miller R; Johnson & Johnson Innovative Medicine, Spring House, Pennsylvania, PA, 19477, USA., Patrick A; Johnson & Johnson Innovative Medicine, Spring House, Pennsylvania, PA, 19477, USA., Pham Q; Johnson & Johnson Innovative Medicine, Brisbane, CA, 94005, USA., Piassek M; Johnson & Johnson Innovative Medicine, Spring House, Pennsylvania, PA, 19477, USA., Verheyen N; Janssen Infectious Diseases and Vaccines, 2340, Beerse, Belgium., Shareef A; Department of Microbiology, National Emerging Infectious Diseases Laboratories, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 02118, USA., Sutto-Ortiz P; Aix Marseille Université, CNRS, AFMB, UMR 7257, Marseille, France., Ysebaert N; Janssen Infectious Diseases and Vaccines, 2340, Beerse, Belgium., Van Vlijmen H; Johnson & Johnson Innovative Medicine, Beerse, Belgium., Jonckers THM; Johnson & Johnson Innovative Medicine, Beerse, Belgium., Herschke F; Janssen Infectious Diseases and Vaccines, 2340, Beerse, Belgium., McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, 78712, USA., Decroly E; Aix Marseille Université, CNRS, AFMB, UMR 7257, Marseille, France., Fearns R; Department of Microbiology, National Emerging Infectious Diseases Laboratories, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 02118, USA., Grosse S; Johnson & Johnson Innovative Medicine, Beerse, Belgium., Roymans D; Janssen Infectious Diseases and Vaccines, 2340, Beerse, Belgium., Sharma S; Johnson & Johnson Innovative Medicine, Spring House, Pennsylvania, PA, 19477, USA., Rigaux P; Janssen Infectious Diseases and Vaccines, 2340, Beerse, Belgium., Jin Z; Johnson & Johnson Innovative Medicine, Brisbane, CA, 94005, USA. zjin14@its.jnj.com.
Publikováno v:
Communications biology [Commun Biol] 2023 Oct 21; Vol. 6 (1), pp. 1074. Date of Electronic Publication: 2023 Oct 21.
Autor:
Kleiner VA; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA., Fearns R; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Publikováno v:
Journal of virology [J Virol] 2024 Aug 20; Vol. 98 (8), pp. e0033224. Date of Electronic Publication: 2024 Jul 30.
Autor:
Bonneux B; Laboratory for Microbiology, Parasitology and Hygiene, University of Antwerp, Universiteitsbaan 1, 2610 Wilrijk, Belgium; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Shareef A; Department of Virology, Immunology & Microbiology, National Emerging Infectious Diseases Laboratories, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA., Tcherniuk S; Unité de Virologie et Immunologie Moléculaires (VIM, UMR892), INRAE, Université Paris-Saclay, 78352 Jouy-en-Josas, France., Anson B; Janssen Research & Development LLC, Spring House (PA 19477) And Brisbane (CA 94005), USA., de Bruyn S; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Verheyen N; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Thys K; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Conceição-Neto N; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Van Ginderen M; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Kwanten L; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Ysebaert N; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Vranckx L; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Peeters E; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Lanckacker E; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Gallup JM; Iowa State University, Ames, IA 50011, USA., Sitthicharoenchai P; Iowa State University, Ames, IA 50011, USA., Alnajjar S; Iowa State University, Ames, IA 50011, USA., Ackermann MR; Iowa State University, Ames, IA 50011, USA., Adhikary S; Janssen Research & Development LLC, Spring House (PA 19477) And Brisbane (CA 94005), USA., Bhaumik A; Janssen Research & Development LLC, Spring House (PA 19477) And Brisbane (CA 94005), USA., Patrick A; Janssen Research & Development LLC, Spring House (PA 19477) And Brisbane (CA 94005), USA., Fung A; Janssen Research & Development LLC, Spring House (PA 19477) And Brisbane (CA 94005), USA., Sutto-Ortiz P; AFMB, Aix-Marseille University, CNRS UMR 7257, 163 Avenue de Luminy, Marseille, France., Decroly E; AFMB, Aix-Marseille University, CNRS UMR 7257, 163 Avenue de Luminy, Marseille, France., Mason SW; Janssen Research & Development LLC, Spring House (PA 19477) And Brisbane (CA 94005), USA., Lançois D; Janssen France, 27106 Val de Reuil, France., Deval J; Janssen Research & Development LLC, Spring House (PA 19477) And Brisbane (CA 94005), USA., Jin Z; Janssen Research & Development LLC, Spring House (PA 19477) And Brisbane (CA 94005), USA., Eléouët JF; Unité de Virologie et Immunologie Moléculaires (VIM, UMR892), INRAE, Université Paris-Saclay, 78352 Jouy-en-Josas, France., Fearns R; Department of Virology, Immunology & Microbiology, National Emerging Infectious Diseases Laboratories, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA., Koul A; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium. Electronic address: akoul@its.jnj.com., Roymans D; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Rigaux P; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Herschke F; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium. Electronic address: fherschk@its.jnj.com.
Publikováno v:
Antiviral research [Antiviral Res] 2024 Jul; Vol. 227, pp. 105907. Date of Electronic Publication: 2024 May 19.
Autor:
Xie J; Roche Pharma Research and Early Development, Lead Discovery, Roche Innovation Center Shanghai, 201203, Shanghai, China., Ouizougun-Oubari M; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 02118, USA., Wang L; Roche Pharma Research and Early Development, Infectious Diseases, Roche Innovation Center Shanghai, 201203, Shanghai, China., Zhai G; Roche Pharma Research and Early Development, Lead Discovery, Roche Innovation Center Shanghai, 201203, Shanghai, China., Wu D; Roche Pharma Research and Early Development, Infectious Diseases, Roche Innovation Center Shanghai, 201203, Shanghai, China., Lin Z; Roche Pharma Research and Early Development, Lead Discovery, Roche Innovation Center Shanghai, 201203, Shanghai, China., Wang M; Wuxi Biortus Biosciences Co. Ltd., 214437, Jiangyin, Jiangsu, China., Ludeke B; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 02118, USA., Yan X; Wuxi Biortus Biosciences Co. Ltd., 214437, Jiangyin, Jiangsu, China., Nilsson T; Roche Pharma Research and Early Development, Infectious Diseases, Roche Innovation Center Basel, Basel, 4070, Switzerland., Gao L; Roche Pharma Research and Early Development, Infectious Diseases, Roche Innovation Center Shanghai, 201203, Shanghai, China. goodlucksept2016@yahoo.com., Huang X; Roche Pharma Research and Early Development, Lead Discovery, Roche Innovation Center Shanghai, 201203, Shanghai, China. xinyi.huang@roche.com., Fearns R; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 02118, USA. rfearns@bu.edu., Chen S; Roche Pharma Research and Early Development, Lead Discovery, Roche Innovation Center Shanghai, 201203, Shanghai, China. shuai.chen.sc1@roche.com.
Publikováno v:
Nature communications [Nat Commun] 2024 Apr 11; Vol. 15 (1), pp. 3163. Date of Electronic Publication: 2024 Apr 11.
Autor:
Ouizougun-Oubari M; Department of Virology, Immunology & Microbiology, National Emerging Infectious Diseases Laboratories, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA; email: rfearns@bu.edu., Fearns R; Department of Virology, Immunology & Microbiology, National Emerging Infectious Diseases Laboratories, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA; email: rfearns@bu.edu.
Publikováno v:
Annual review of virology [Annu Rev Virol] 2023 Sep 29; Vol. 10 (1), pp. 199-215. Date of Electronic Publication: 2023 May 03.
Autor:
Aihara F; Department of Microbiology, Boston University, Boston, MA., Wang Y; Department of Microbiology, Boston University, Boston, MA., Belkina AC; Department of Microbiology, Boston University, Boston, MA., Fearns R; Department of Microbiology, Boston University, Boston, MA., Mizgerd JP; Department of Microbiology, Boston University, Boston, MA., Feng F; Department of Microbiology, Boston University, Boston, MA., Kepler TB; Department of Microbiology, Boston University, Boston, MA.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2023 Aug 01; Vol. 211 (3), pp. 486-496.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kleiner VA; Department of Virology, Immunology & Microbiology, National Emerging Infectious Diseases Laboratories, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA., O Fischmann T; MRL, Merck & Co., Inc., Rahway, NJ, USA., Howe JA; MRL, Merck & Co., Inc., Rahway, NJ, USA., Beshore DC; MRL, Merck & Co., Inc., Rahway, NJ, USA., Eddins MJ; MRL, Merck & Co., Inc., Rahway, NJ, USA., Hou Y; MRL, Merck & Co., Inc., Rahway, NJ, USA., Mayhood T; MRL, Merck & Co., Inc., Rahway, NJ, USA., Klein D; MRL, Merck & Co., Inc., Rahway, NJ, USA., Nahas DD; MRL, Merck & Co., Inc., Rahway, NJ, USA., Lucas BJ; MRL, Merck & Co., Inc., Rahway, NJ, USA., Xi H; MRL, Merck & Co., Inc., Rahway, NJ, USA., Murray E; MRL, Merck & Co., Inc., Rahway, NJ, USA., Ma DY; MRL, Merck & Co., Inc., Rahway, NJ, USA., Getty K; MRL, Merck & Co., Inc., Rahway, NJ, USA., Fearns R; Department of Virology, Immunology & Microbiology, National Emerging Infectious Diseases Laboratories, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA. rfearns@bu.edu.
Publikováno v:
Communications biology [Commun Biol] 2023 Jun 19; Vol. 6 (1), pp. 649. Date of Electronic Publication: 2023 Jun 19.